Discovery Platform
A Powerful Tech Stack for Validating Difficult Targets
AI-Powered Precision Antibody Therapeutics
Epitope-Steering and Antibody Optimization
Therapeutic Pipeline
RAPIDLY ADVANCING HARD-TO-ENGINEER ANTIBODIES
Obesity and Cardiometabolic Conditions
Collaborating to develop first-in-class and best-in-class molecules for obesity, diabetes, and heart disease
Immuno-Oncology
Advancing our preclinical pipeline and innovating with our partners to overcome oncology’s discovery and development challenges
Partner with iBio
License our discovery platform or collaborate with us to advance our high-value pipeline assets
Discovery Platform
From precision antibody identification and optimization to tailored bispecifics and a cutting-edge masking technology
Antibody Masking With ShieldTx™
An antibody masking technology for delivering on-epitope, on-tissue clinical candidates with enhanced safety and developability
Optimize Bispecifics With EngageTx™
a CD3-BASED T-CELL ENGAGER Platform
Therapeutic Candidates
Learn how we are deploying our AI Drug Discovery Platform to develop a robust immuno-oncology pipeline
The Expertise Behind the AI
Meet the team driving iBio’s powerful tech stack for drug discovery
